Specialty Pharmacy

Increased amount of specific fatty acid underlies type 1 diabetes and obesity-related kidney dysfunction.

A new treatment for hepatitis B significantly reduced viral load in 4 weeks.

Infertility and breast density may impact the risk of cancer.

Combination treatment approach helps control diabetes and obesity.

Top news of the day from across the healthcare landscape.

When anti-microbial antibodies have accumulated for years before a person is diagnosed with Crohn’s disease, it is likely to increase complications.

Targeted approach may lead to improved treatments for cancer.

Prognostic model provides simple and accurate clinical description for each HCC patient.

JAK2 could potentially cause treatment resistance in TNBC.

Bevespi Aerosphere is a twice-daily, fixed-dose dual bronchodilator combining a long-acting muscarcinic antagonist and a long-acting beta-2 agonist.

Top news of the day from across the health care landscape.

Pharmacist-led diabetes collaborative drug therapy management programs impact patients with type 2 diabetes.

Vitamin D deficiency has been associated with different cancer types, such as breast, lung, colon, and bladder cancers.

Cortistatin A is a natural product isolated from an Indonesian marine sponge with potent anti-angiogenic activity at low dosages.

Recent advances and updates in oncology and cancer drug development.

Fecal transplants may transfer viruses along with desirable bacteria.

Adherence to antiretroviral treatment negatively affected among patients with HIV who use drugs.

Top news of the day from across the health care landscape.

Chinese plant Huang-Qin compound shows promise treating cancer and liver disease.

CTLA-4 molecule on T cells offer potential therapeutic target.

Top stories of the week on Specialty Pharmacy Times.

Decision will make direct-acting antivirals available to 40% of the state's estimated 60,000 Medicaid patients with chronic HCV.

Lack of social support among the leading risk factors for anxiety among COPD patients.

HIV continues to replicate in macrophages even without T-cells.

The FDA has issued 3 draft guidance documents that clarify how it intends to enforce the prescription requirement for drugs compounded by health-system pharmacies.

Study reports the second known real world data set for HCV patients coinfected with HIV treated with Sovaldi or Harvoni.

High prevalence of anti-HIV antibodies found in patients with hepatitis C and hepatitis B.

Methotrexate and decadron could lower relapse rates of patients with acute lymphoblastic leukemia.